Treatment of Inflammatory Bowel Disease in the Older Patient

被引：4

作者：

Dorreen, Alastair ^{[1
]}

Heisler, Courtney ^{[2
]}

Jones, Jennifer ^{[2
,3
]}

机构：

[1] Univ Ottawa, Dept Med, Ottawa, ON, Canada

[2] Dalhousie Univ, Dept Med, Halifax, NS, Canada

[3] Dalhousie Univ, Dept Epidemiol & Biostat, Halifax, NS, Canada

来源：

INFLAMMATORY BOWEL DISEASES | 2018年 / 24卷 / 06期

关键词：

advanced age; Crohn's disease; inflammatory bowel disease; treatment; adverse events; POPULATION-BASED COHORT; ANTI-TNF THERAPY; CLINICAL-PRACTICE GUIDELINES; POUCH-ANAL ANASTOMOSIS; LOW-GRADE DYSPLASIA; CROHNS-DISEASE; ULCERATIVE-COLITIS; ELDERLY-PATIENTS; MAINTENANCE THERAPY; COLORECTAL-CANCER;

D O I：

10.1093/ibd/izy023

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The incidence of inflammatory bowel disease (IBD) is increasing, and as our population ages, there is a growing number of IBD patients who are transitioning into advanced age; 15% to 20% of IBD patients are classified as late-onset (between 60-65 years of age). This has led clinicians to treat a large number of older patients with IBD. The principles of management of IBD in older patients are the same as those who are younger. There are, however, phenotypic differences that are unique to late-onset IBD and age-related concerns that clinicians must consider when initiating therapy for their older patients with IBD. Given the increasing number of older IBD patients, the aim of this article is to present an updated, evidence-based review of the therapeutic options and issues that arise in this unique patient population.

引用

页码：1155 / 1166

页数：12

共 50 条

[21] Patient Satisfaction With Infusion Therapy Site for Treatment of Inflammatory Bowel Disease
Vermeulen, David H., II
Berg, Hannah J.
Graziano, Elliot
Vaughn, Byron
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S394 - S394
[22] Tailoring Treatment to the Individual Patient - Will Inflammatory Bowel Disease Medicine Be Personalized?
Fiocchi, Claudio
DIGESTIVE DISEASES, 2015, 33 : 82 - 89
[23] Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease
Siegel, Corey A.
Levy, Campbell
Mackenzie, Todd A.
Sands, Bruce E.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S438 - S438
[24] DEVELOPING TREATMENT ATTRIBUTES FOR A PATIENT PREFERENCE SURVEY IN INFLAMMATORY BOWEL DISEASE
Schoefs, E.
Vermeire, S.
Ferrante, M.
Sabino, J.
Verstockt, B.
Avedano, L.
Haaf, I
De Rocchis, M. S.
Broggi, A.
Sajak-Szczerba, M.
Saldana, R.
Huys, I
Janssens, R.
VALUE IN HEALTH, 2022, 25 (12) : S434 - S434
[25] My Treatment Approach to Management of the Pregnant Patient With Inflammatory Bowel Disease
Ng, Susie W.
Mahadevan, Uma
MAYO CLINIC PROCEEDINGS, 2014, 89 (03) : 355 - 360
[26] Older Adults With Inflammatory Bowel Disease in Canada
Rohatinsky, Noelle
Chauhan, Usha
Currie, Barbara
Peacock, Shelley
Phalen-Kelly, Kelly
Russell, Brooke
Tooke, Natasha
GASTROENTEROLOGY NURSING, 2024, 47 (01) : 41 - 51
[27] Age of older siblings and inflammatory bowel disease
Montgomery, SM
Pounder, RE
Wakefield, AJ
GUT, 1999, 44 : A29 - A29
[28] INFLAMMATORY BOWEL-DISEASE IN OLDER PATIENTS
FLEISCHER, DE
GRIMM, IS
FRIEDMAN, LS
MEDICAL CLINICS OF NORTH AMERICA, 1994, 78 (06) : 1303 - 1319
[29] Patient and physician perspectives on the management of inflammatory bowel disease: Disease remission and durability of treatment
Afzali, A.
Armuzzi, A.
Bouhnik, Y.
Bressler, B.
Hart, A.
Rubin, D.
Sans, M.
Siegmund, B.
Sninsky, C.
JOURNAL OF CROHNS & COLITIS, 2020, 14 : S424 - S424
[30] PATIENT AND PHYSICIAN PERSPECTIVES ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE: DISEASE REMISSION AND DURABILITY OF TREATMENT
Afzali, Anita
Armuzzi, Alessandro
Bouhnik, Yoram
Bressler, Brian
Hart, Ailsa
Rubin, David T.
Sans, Miguel
Siegmund, Britta
Sninsky, Charles
GASTROENTEROLOGY, 2020, 158 (06) : S663 - S663

← 1 2 3 4 5 →